Fundraising Fox株式会社京都創薬研究所
Kyoto, JP · 2 known investors
Find your way into 株式会社京都創薬研究所
Sign up to see every warm intro you have to 株式会社京都創薬研究所
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社京都創薬研究所 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kyoto Drug develops novel therapeutic drugs for rare and difficult-to-treat ocular diseases including retinal artery occlusion and retinitis pigmentosa, using a new small-molecule compound (KUS agent) based on research from Kyoto University.
Founders & leadership
M(
Musashi (武蔵)CEO
Investors · 2
Frequently asked questions
- What does 株式会社京都創薬研究所 do?
- Kyoto Drug develops novel therapeutic drugs for rare and difficult-to-treat ocular diseases including retinal artery occlusion and retinitis pigmentosa, using a new small-molecule compound (KUS agent) based on research from Kyoto University.
- Who are 株式会社京都創薬研究所's investors?
- 株式会社京都創薬研究所's investors include Kyoto University Innovation Capital, Miyako Capital.
- Where is 株式会社京都創薬研究所 headquartered?
- 株式会社京都創薬研究所 is headquartered in Kyoto, JP.